BAX earnings call for the period ending June 30, 2020.
News & Analysis: Baxter
BAX earnings call for the period ending March 31, 2020.
The giant healthcare company saw increased demand in Q1 for several products due to the coronavirus pandemic.
Coronavirus patients in intensive care units are using more dialysis fluids than anyone expected.
The healthcare giant's medication delivery business provided its strongest growth in Q4.
Over a three-year period, the pharmaceutical giant reported it made $278 million more than it really did.
This new technology could have wide appeal in hospitals around the world.
Accounting issues overshadowed third-quarter results.
The numbers didn't matter with the healthcare giant's Q3 update. Investors have a bigger worry.
The healthcare giant's relatively strong preliminary third-quarter results were overshadowed by two other developments.